Saturday, October 31, 2026

Major Earthquake Shakes Ecuador

Mark Silva

April 17, 2016

Ecuador earthquake supermarket aftermath 2016-04-16
A Magnitude 7.8 earthquake strikes off the shore of Ecuador 27km South Southeast of Muisne, 19.2 km deep. According to the USGS (Earthquake Hazards Program) from the U.S. Geological Survey, seven earthquakes above Magnitude 4.5 have hit Ecuador in the last 7 hours. The USGS monitors and reports earthquakes and research the causes and effects of earthquakes. The strongest Ecuador earthquake was magnitude 7.8 at 23:58:37 UTC. The last big earthquake in Ecuador was on 12 August 2010 with a 7.1 magnitude.

Above 4.5 earthquakes in Ecuador in the last 8 hours

MagnitudeLocationDateDepth
4.844km NNW of Bahia de Caraquez2016-04-17 04:02:08 UTC10.0 km
4.533km NW of Pedernales2016-04-17 03:05:33 UTC10.0 km
4.834km NNE of Bahia de Caraquez2016-04-17 02:18:01 UTC10.0 km
4.543km SW of Muisne2016-04-17 00:59:07 UTC27.3 km
5.434km N of Bahia de Caraquez2016-04-17 00:29:32 UTC14.2 km
7.827km SSE of Muisne2016-04-16 23:58:37 UTC19.2 km
4.821km N of Pedernales2016-04-16 23:47:44 UTC33.0 km
Ecuador president, Rafael Correa, has already declared a national emergency.
"I just signed a decree of emergency and national mobilization. Today, more united than ever. In our infinite love to the families of the deceased." Rafael Correa, President of Ecuador, on Twitter

Tsunami threat dismissed

According to the Pacific Tsunami Warning Center, the previously tsunami threat is now out of the question.
"BASED ON ALL DATA AVAILABLE TO THIS CENTER... THE TSUNAMI THREAT FROM THIS EARTHQUAKE HAS NOW MOSTLY PASSED. ANY REMAINING THREAT SHOULD BE EVALUATED BY LOCAL AUTHORITIES IN IMPACTED AREAS." Source Pacific Tsunami Warning Center
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com